Immunoproliferative Disorders  >>  BMS  >>  Phase 1
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
            
             
marizomib (NPI-0052) / Triphase Accelerator Corporation, BMS           
          
            
             
urelumab (BMS-663513) / BMS, Ono Pharma           
          
            
             
Angiocept (pegdinetanib) / BMS           
          
            
             
BMS-833923 / BMS           
          
            
             
BMS-936559 / BMS           
          
            
             
MDX-1203 / BMS           
          
            
             
MDX-1342 / BMS           
          
            
             
Onureg (azacitidine oral) / BMS